Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • ROOMS:

Disappointing Results For Catalyst Pharmaceutical

Catalyst Pharmaceutical Partners Inc. (Nasdaq: CPRX) reported disappointing results from a Phase II(b) clinical trial of its cocaine addiction treatment CPP-109 sending the stock price plummeting 95 cents to close at $0.50.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.